logo

For the Inventor, By the Inventor

Research Triangle Park, NC, United States of America

Alphavax, Incorporated


USPTO Granted Patents = 19

% Expired Patents = 10.5



Trademarks = 1

Forward Citations = 326

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Jonathan F Smith (16 out of 41 patents)

silverMedal Kurt Iver Kamrud (9 out of 24 patents)

bronzeMedal Bolyn Hubby (7 out of 7 patents)

4.  Jon O Rayner (6 out of 6 patents)

5.  Sergey A Dryga (5 out of 36 patents)

6.  Elizabeth A Reap (5 out of 5 patents)

7.  Laura Copp (3 out of 3 patents)

8.  Ian Caley (3 out of 4 patents)

9.  Maureen Maughan (3 out of 4 patents)

10.  Vernon McNeil Coffield, Iii (2 out of 3 patents)

11.  Jonathan O Rayner (2 out of 2 patents)

12.  Ronald I Swanstrom (1 out of 5 patents)

13.  Lynn Morris (1 out of 2 patents)

14.  Todd L Talarico (1 out of 1 patent)

15.  Roberto A DePaz (1 out of 1 patent)


19 patents:

1. 10570416 - TC-83-derived alphavirus vectors, particles and methods (2020-02-25),
2. 10111943 - Alphavirus replicon particles matched to protein antigens as immunological adjuvants (2018-10-30),
3. 9597414 - Use of microRNAs to control virus helper nucleic acids (2017-03-21),
4. 9441247 - TC-83-derived alphavirus vectors, particles and methods (2016-09-13),
5. 9416370 - Alphavirus replicon particles matched to protein antigens as immunological adjuvants (2016-08-16),
6. 9187729 - Alphavirus and alphavirus replicon particle formulations and methods (2015-11-17),
7. 9079943 - TC-83-derived alphavirus vectors, particles and methods (2015-07-14),
8. 8709441 - TC-83-derived alphavirus vectors, particles and methods (2014-04-29),
9. 8680258 - Use of microRNAs to control virus helper nucleic acids (2014-03-25),
10. 8617533 - Multi-antigenic alphavirus replicon particles and methods (2013-12-31),
11. 8460913 - Promoterless cassettes for expression of alpha virus structural proteins (2013-06-11),
12. 8263092 - Alphavirus replicon particles as immunological adjuvants (2012-09-11),
13. 7910716 - Nucleic acids encoding modified South African HIV-1 subtype C gag proteins (2011-03-22),
14. 7850977 - Promoterless cassettes for expression of alphavirus structural proteins (2010-12-14),
15. 7442381 - Alphavirus replicons and helper constructs (2008-10-28),
Company Overview
Alphavax, Incorporated is a biotechnology company based in Research Triangle Park, North Carolina, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing its proprietary technologies in the fields of vaccine development and immunotherapy, aiming to address significant unmet medical needs. With a commitment to scientific excellence, Alphavax leverages cutting-edge research to create impactful health solutions that enhance patient outcomes and contribute to global health advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#22 in Research Triangle Park, NC

#381 in North Carolina

#17,150 in US

#32,693 in the World

Research Triangle Park, NC (US)
Research Triangle Park, NC, United States of America

Alphavax, Incorporated

Forward Citations = 326

25 inventors:

goldMedal Jonathan F Smith (16 out of 41 patents)

silverMedal Kurt Iver Kamrud (9 out of 24 patents)

bronzeMedal Bolyn Hubby (7 out of 7 patents)

4.  Jon O Rayner (6 out of 6 patents)

5.  Sergey A Dryga (5 out of 36 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alphavax, Incorporated. Retrieved from https://idiyas.com/company/alphavax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…